19-2431172-G-A

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_032737.4(LMNB2):​c.1822-220C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0595 in 152,272 control chromosomes in the GnomAD database, including 425 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.060 ( 425 hom., cov: 33)

Consequence

LMNB2
NM_032737.4 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.669

Publications

3 publications found
Variant links:
Genes affected
LMNB2 (HGNC:6638): (lamin B2) This gene encodes a B type nuclear lamin. The nuclear lamina consists of a two-dimensional matrix of proteins located next to the inner nuclear membrane. The lamin family of proteins make up the matrix and are highly conserved in evolution. During mitosis, the lamina matrix is reversibly disassembled as the lamin proteins are phosphorylated. Lamin proteins are thought to be involved in nuclear stability, chromatin structure and gene expression. Vertebrate lamins consist of two types, A and B. Mutations in this gene are associated with acquired partial lipodystrophy. [provided by RefSeq, May 2012]
LMNB2 Gene-Disease associations (from GenCC):
  • microcephaly 27, primary, autosomal dominant
    Inheritance: AD Classification: STRONG, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
  • progressive myoclonic epilepsy type 9
    Inheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae)
  • microcephaly
    Inheritance: AD Classification: MODERATE Submitted by: Franklin by Genoox
  • lipodystrophy, partial, acquired, susceptibility to
    Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • central nervous system malformation
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.94).
BP6
Variant 19-2431172-G-A is Benign according to our data. Variant chr19-2431172-G-A is described in ClinVar as Benign. ClinVar VariationId is 1229867.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.248 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_032737.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LMNB2
NM_032737.4
MANE Select
c.1822-220C>T
intron
N/ANP_116126.3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LMNB2
ENST00000325327.4
TSL:1 MANE Select
c.1822-220C>T
intron
N/AENSP00000327054.3Q03252
LMNB2
ENST00000917224.1
c.1963-220C>T
intron
N/AENSP00000587283.1
LMNB2
ENST00000917223.1
c.1828-220C>T
intron
N/AENSP00000587282.1

Frequencies

GnomAD3 genomes
AF:
0.0595
AC:
9058
AN:
152154
Hom.:
426
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0676
Gnomad AMI
AF:
0.0351
Gnomad AMR
AF:
0.0636
Gnomad ASJ
AF:
0.0349
Gnomad EAS
AF:
0.261
Gnomad SAS
AF:
0.110
Gnomad FIN
AF:
0.0367
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0408
Gnomad OTH
AF:
0.0406
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0595
AC:
9062
AN:
152272
Hom.:
425
Cov.:
33
AF XY:
0.0622
AC XY:
4633
AN XY:
74460
show subpopulations
African (AFR)
AF:
0.0675
AC:
2805
AN:
41536
American (AMR)
AF:
0.0634
AC:
970
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.0349
AC:
121
AN:
3470
East Asian (EAS)
AF:
0.260
AC:
1346
AN:
5182
South Asian (SAS)
AF:
0.110
AC:
533
AN:
4830
European-Finnish (FIN)
AF:
0.0367
AC:
390
AN:
10618
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0408
AC:
2772
AN:
68016
Other (OTH)
AF:
0.0440
AC:
93
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
424
848
1272
1696
2120
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
106
212
318
424
530
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0197
Hom.:
7
Bravo
AF:
0.0600
Asia WGS
AF:
0.167
AC:
581
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.94
CADD
Benign
1.7
DANN
Benign
0.68
PhyloP100
-0.67
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs60073269; hg19: chr19-2431170; API